Full-Time

Journey Clinical is seeking a

Licensed Telehealth Psychiatric Nurse Practitioner, Pmhnp

Journey Clinical

Journey Clinical

51-200 employees

Ketamine-assisted psychotherapy with medical oversight

No salary listed

Remote in USA

Remote

CT license required; telehealth remote role.

Category
Medical, Clinical & Veterinary (1)

Get referred to Journey Clinical

See people who can refer or advise you

Requirements
  • Licensed to practice in Connecticut
  • Minimum 1 year psych related experience + post boards
  • DEA registration
  • Comfortable prescribing controlled substances when medically appropriate
  • Comfortable prescribing for anxiety and depression
  • Ability to quickly synthesize medical and psychiatric information about the patient to formulate effective and evidence-based clinical recommendations
  • Patient-first mindset, deep work ethic and dedication to the highest level of patient care
  • Willing to use a few simple tools to make your life easier (Slack, G Suite, Zoom, etc.)
  • Comfortable working remotely in a Telehealth fast-paced startup environment
  • Interest for the field of psychedelic-assisted psychotherapy to transform mental health
  • Preferred: 1 year psych experience as a PMHNP
Responsibilities
  • Conduct patient intake and follow up consultations to evaluate ketamine-assisted psychotherapy (KAP) eligibility, prescribe, and monitor patient outcomes via telemedicine
  • Suggest treatment plan changes based on patient response to medication and treatment outcomes
  • Engage in collaborative care with Journey Clinical member psychotherapists
  • Work with Journey Clinical care coordinator to streamline your workflow
  • Continuously and promptly give honest feedback on the Journey Clinical care management system to improve our services
  • Report directly to the Lead Clinician and collaborate with the leadership team and the co-founders
Desired Qualifications
  • Preferred: 1 year psych experience as a PMHNP
  • Interest for the field of psychedelic-assisted psychotherapy to transform mental health

Journey Clinical offers Ketamine-Assisted Psychotherapy (KAP) for depression, anxiety, and PTSD. It acts as a one-stop treatment partner where a medical consultation leads to ketamine prescription, administration, and accompanying psychotherapy in a coordinated care plan. The approach blends ketamine's effects with structured psychotherapy to tackle symptoms from multiple angles under medical oversight. The company stands out with a patient-centered, collaborative care model and a team of MDs, PhDs, and licensed clinicians delivering personalized, accessible therapy.

Company Size

51-200

Company Stage

Series A

Total Funding

$11.5M

Headquarters

New York City, null

Founded

2020

Get referred to Journey Clinical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Journey Clinical updated its site on August 28, 2026 with active KAP resources.
  • The company still markets KAP for anxiety, depression, PTSD, and Spravato.
  • Partnership-driven distribution expands therapist supply without heavy clinic capex.

What critics are saying

  • Off-label ketamine anchors revenue to a single, crowded treatment niche.
  • A 2026 federal enforcement shift can squeeze psychedelic providers within months.
  • If FDA blocks broader psychedelic delivery, Journey Clinical loses its expansion thesis.

What makes Journey Clinical unique

  • Journey Clinical launched a nationwide KAP therapist directory on April 16, 2026.
  • It pairs ketamine, licensed therapists, and medical monitoring in one workflow.
  • The platform supports insurance coverage and remote dosing, lowering patient friction.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Remote Work Options

Training Programs

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

-3%

1 year growth

0%

2 year growth

2%
The Juniper Center
Aug 4th, 2025
What is Ketamine-Assisted Psychotherapy?

For those curious to learn more, The Juniper Center has partnered with Journey Clinical - a platform that connects therapists with licensed prescribers and offers research and resources on KAP for both clients and providers.

Gateway to Solutions
Jun 21st, 2024
Ketamine-Assisted Psychotherapy (KAP) at Gateway to Solutions

Gateway to Solutions, a trusted provider of ketamine-assisted psychotherapy for eight years, has recently partnered with Journey Clinical for a seamless and collaborative KAP experience.

Crain Communications
May 1st, 2024
Compass Pathways, Journey Clinical to develop psilocybin treatment delivery model

Compass Pathways plc (Nasdaq: CMPS) entered into a research collaboration agreement this week with Journey Clinical, a U.S.-based psychedelic-assisted psychotherapy platform.

Journey Clinical
Dec 19th, 2023
Building a Network of KAP Providers with IPI

This October, Journey Clinical launched a partnership with the Integrative Psychiatry Institute (IPI) to support their students and graduates in becoming successful Ketamine-Assisted Psychotherapy providers.

Journey Clinical
Apr 10th, 2023
SXSW Panel: The Business of Psychedelics featuring Myriam Barthes

Journey Clinical partnered up with Fluence to offer some training and then they also needed professional resource in order to grow their practice.